Literature DB >> 5969245

Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility.

B J Sobol.   

Abstract

Mesh:

Year:  1966        PMID: 5969245      PMCID: PMC1019068          DOI: 10.1136/thx.21.5.445

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

1.  SUBJECT EFFORT AND THE EXPIRATORY FLOW RATE.

Authors:  B J SOBOL; C EMIRGIL
Journal:  Am Rev Respir Dis       Date:  1964-03

2.  Spirometric studies in normal subjects. II. Ventilatory capacity tests in adults.

Authors:  G BIRATH; I KJELLMER; L SANDQVIST
Journal:  Acta Med Scand       Date:  1963-02

3.  Peak expiratory flow measured by the Wright peak flow meter. Distribution of values in men aged 30-59 who denied respiratory symptoms.

Authors:  C M TINKER
Journal:  Br Med J       Date:  1961-05-13

4.  The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men.

Authors:  R C KORY; R CALLAHAN; H G BOREN; J C SYNER
Journal:  Am J Med       Date:  1961-02       Impact factor: 4.965

5.  Relationship of height to lung volume in healthy men.

Authors:  N G HEPPER; W S FOWLER; H F HELMHOLZ
Journal:  Dis Chest       Date:  1960-03

6.  Maximal midexpiratory flow.

Authors:  E C LEUALLEN; W S FOWLER
Journal:  Am Rev Tuberc       Date:  1955-12

7.  Normal standards for lung volumes, intrapulmonary gas-mixing, and maximum breathing capacity.

Authors:  C D NEEDHAM; M C ROGAN; I McDONALD
Journal:  Thorax       Date:  1954-12       Impact factor: 9.139

8.  A comparison of forced expiratory volume and peak flow in clinical practice.

Authors:  B RITCHIE
Journal:  Lancet       Date:  1962-08-11       Impact factor: 79.321

9.  The maximal midexpiratory flow: a re-examination.

Authors:  B J Sobol
Journal:  Am Rev Respir Dis       Date:  1965-12
  9 in total
  15 in total

Review 1.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies.

Authors:  H A Kerstjens; B Rijcken; J P Schouten; D S Postma
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

2.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

3.  Predicted values: how should we use them?

Authors:  M R Miller; A C Pincock
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

4.  Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach.

Authors:  B J Sobol; P G Sobol
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

5.  Lung function in rheumatoid arthritis. A clinic survey.

Authors:  C Davidson; A G Brooks; P A Bacon
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

6.  LS-MFT: lung screening by meaningful function testing. I.

Authors:  D P Discher
Journal:  Am J Public Health Nations Health       Date:  1970-11

7.  Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits.

Authors:  P M Tweeddale; S Merchant; M Leslie; F Alexander; G J McHardy
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

8.  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Authors:  Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

9.  Reference values and prediction equations for normal lung function in a non-smoking white urban population.

Authors:  C M Roberts; K D MacRae; A J Winning; L Adams; W A Seed
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

Review 10.  What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Authors:  Nitin Y Bhatt; Karen L Wood
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.